Małgorzata Żurawska

Ministry of Interior — Italy

Medicine · Health Sciences

6h-index142citations19works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Mechanisms and Therapy(6), Atrial Fibrillation Management and Outcomes(5), Synthesis and biological activity(3), Cardiac Valve Diseases and Treatments(2), Multiple Myeloma Research and Treatments(2)

Publications19 total

Robotic mitral repair in echocardiographically symmetrical and asymmetrical Barlow’s disease
Annals of Cardiothoracic Surgery·2026Open Access
Comparative Analysis of Long-Term Outcomes in Valve-Sparing Aortic Root Reimplantation: Full Sternotomy versus Mini-Sternotomy Approach
Journal of Clinical Medicine·2024· 1 citedOpen Access
Egzamin z kardiologii. Tom 1
2024
Rapid pharmacological cardioversion of recent-onset atrial fibrillation using antazoline in elderly patients
Polskie Archiwum Medycyny Wewnętrznej·2021· 3 citedOpen Access
Development of a multiplexed protein panel using a targeted proteomics approach for the study of CDK4/6 inhibitors resistance in hormone receptor positive breast cancer
European Journal of Cancer·2020
5-Keto-3-cyano-2,4-diaminothiophenes as selective maternal embryonic leucine zipper kinase inhibitors
Bioorganic & Medicinal Chemistry Letters·2018· 8 citedOpen Access
Clinical effectiveness and safety of antazoline‐based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short‐duration atrial fibrillation in the emergency department
Cardiovascular Therapeutics·2018· 10 citedOpen Access
A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia
Oncotarget·2018· 35 citedOpen Access
Effective Crisis and Emergency Responses in the Multinational Corporation
2017· 12 cited
P2697Utility of antazoline for cardioversion of recent onset atrial fibrillation in patients with a history of myocardial infarction
European Heart Journal·2017
Abstract 4087: Development of a potent, dual pan-PIM/FLT3 inhibitor for the treatment of heme malignancies
Cancer Research·2017
P298Intravenous antazoline for cardioversion of recent onset atrial fibrillation in patients with stable coronary artery disease
EP Europace·2017Open Access
Comparative effectiveness and safety of antazoline‑based and propafenone‑based strategies for pharmacological cardioversion of short‑duration atrial fibrillation in the emergency department
Polskie Archiwum Medycyny Wewnętrznej·2016· 21 cited
Abstract 755: Repression of tumor survival pathways by novel and selective inhibitors of MNK1 and MNK2 kinases in glioblastoma and colorectal cancer
Cancer Research·2014
Abstract 3245: Identification of potent, dual PIM/FLT3 kinase inhibitors for AML treatment.
Cancer Research·2013· 1 cited
Abstract 696: Development of selective CDK8 inhibitors for colorectal cancer and mantle cell lymphoma treatment.
Cancer Research·2013
Abstract 2826: Preclinical development of a Pim kinase inhibitor for cancer treatment
Cancer Research·2012· 1 cited
Kynurenic acid in human renal cell carcinoma: its antiproliferative and antimigrative action on Caki-2 cells
Amino Acids·2012· 50 cited
Abstract A243: Novel Pim kinase inhibitors for treatment of hematological malignancies and solid tumors.
Molecular Cancer Therapeutics·2011

Frequent Co-authors

Krzysztof Brzózka(8), Renata Windak(7), Mariusz Milik(6), Wojciech Czardybon(5), Aleksandra Sabiniarz(5), Magdalena Salwińska(5), Aleksander Maciąg(5), Mariusz Pytkowski(5), Ilona Kowalik(5), Hanna Szwed(5), Ewelina Wincza(4), Karolina Krawczyńska(4), Ewa Trębacz(4), Tomasz Rzymski(4), Michał Gałȩzowski(3), Izabela Dolata(3), Magdalena Zawadzka(3), Bożena Winnik(3), Ewa Kolasińska(3), Marta Bugaj(3)